PubMed · 10426403
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
J S Ebersole. 1999. EEG source modeling. The first word.. https://doi.org/10.1097/00004691-199905000-00001
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
The Characeae internodal cell is excitable and generates an action potential. The depolarizing phase of the action potential primarily reflects the activation of Cl- channels, which takes place in a Ca2+-dependent manner. Namely, an increase in the Ca2+ influx takes place at the very beginning of the action potential and heightens the Ca2+ concentration in the cytoplasm ([Ca2+]c). The high [Ca2+]c activates Cl- channels at the plasmalemma, resulting in a large depolarization. The high [Ca2+]c also acts as a signal to induce a tonoplast action potential and the instantaneous cessation of cytoplasmic streaming; the tonoplast action potential also is caused by Ca2+-induced activation of Cl- channels at the tonoplast, and the cessation is a result of inhibition of the actin-myosin interaction by Ca2+. When the cytoplasm of the Characeae cell, especially in Nitella flexilis, is hydrated rapidly, [Ca2+], also increases through Ca2+ release from an intracellular store(s). The release may be triggered by the stretching of endomembranes caused by osmotic swelling of the Ca2+ store lumens. Although the origin of Ca2+ is different from that in the case of an action potential, high [Ca2+]c not only induces membrane depolarization through activation of the Cl- channel in a Ca2+-dependent manner but also inhibits cytoplasmic streaming in Characeae.
Relationships between presynaptic function and short- and long-term plasticity were investigated at adult corticostriatal synapses. Wide variability was observed in the expression of short- and long-term synaptic plasticity. Intracellular records from 47 cells produced 17 examples of LTD (<90% of control), 10 examples of no long-term change (between 90-110% of control), and 20 examples of LTP (>110% of control). Similar variation existed in paired-pulse and posttetanic plasticities. The variability expressed in all three forms of plasticity appears to be related, based on correlations found between the paired-pulse ratio (PPR) and tetanus-induced short- (3 min posttetanus) and long-term plasticities (16-20 min posttetanus). These data suggest that tetanus-induced changes in synaptic strength are related to the intrinsic, preconditioned behavior of synapses. Every cell showing paired-pulse depression also expressed LTD in response to high-frequency activation of its afferents. Those synapses showing paired-pulse potentiation tended to express LTP, although exceptions did exist. Similar relationships were found in a parallel analysis of population spikes. PPR also changed in association with the expression of posttetanic and long-term depression. Greater paired-pulse potentiation was observed in medial intracellular recordings, but no medial to lateral differences were seen in posttetanic plasticities. Field recordings also showed a medial bias toward paired-pulse and posttetanic potentiation, but not in long-term plasticity. Block of postsynaptic L-type Ca(2+) channels with nifedipine eliminated LTD expression, but overall no differences were found between nifedipine and control cells.
The aim of these studies was to establish a rapid in vivo assay for evaluating potential "cocaine antagonists," i.e., drugs postulated to block cocaine binding to the dopamine transporter (DAT) without corresponding blockade of dopamine reuptake. The assay is based on the ability of dopamine, and drugs that elevate synaptic dopamine levels, to inhibit the extracellular single unit activities of midbrain dopamine neurons in chloral hydrate-anesthetized rats. As expected, cocaine itself (0.06-16 mg/kg, i.v.) caused a dose-dependent inhibition of firing of both substantia nigra and ventral tegmental area (VTA) dopamine neurons, but had a significantly higher potency on VTA than nigral dopamine cells (ED(50)'s 1.2 and 8.8 mg/kg, respectively). VTA cells were also inhibited to a greater extent (to 4.7 +/- 4.5% vs. 41.3 +/- 6.3% of baseline rates at 16 mg/kg, respectively). We next evaluated GBR12909, a piperazine analog promoted as a "cocaine antagonist" because of its ability to bind with high affinity to the DAT, while only modestly elevating extracellular dopamine levels. The agonist- and antagonist-like properties of GBR12909 were evaluated on only VTA dopamine cells since these neurons were more fully inhibited by cocaine and have been implicated in its rewarding effects. Given alone, GBR12909 exhibited modest "cocaine-like" activity insofar as it partially inhibited VTA dopamine neurons (to 59.0 +/- 4.6% of baseline at 8 mg/kg). However, consistent with an antagonist profile, pretreatment with a low (0.5 mg/kg) dose of GBR12909, which depressed firing only slightly, resulted in a >2-fold rightward shift in the dose-response curve to cocaine (ED(50) 2.6 mg/kg). We conclude that electrophysiological testing of putative "anti-cocaine" drugs for their abilities to inhibit the firing of VTA dopamine neurons, and to block their inhibitory responses to cocaine, may provide a rapid in vivo screen for compounds expected to behave as functional cocaine antagonists in the dopamine reward system.